Wayne State University is home to Michigan’s largest multiple sclerosis (MS) clinic, and one of the five largest in the country.

As March -- MS Awareness Month -- draws to a close, researchers and physicians at Wayne State are continuing to build on their world-renowned research and treatment for the neurological disorder. 

Dr. Omar Khan, director of the Wayne State MS Research Center and neurologist-in-chief at the Detroit Medical Center, led the development of a new drug treatment for MS patients that was approved by the FDA in January. The new drug regimen reduces the number of Copaxone (the most prescribed MS drug in the world) injections patients need by 60 percent.

“This study confirms a concept that originated at Wayne State University and will impact the entire field,” Khan said. “I take great pride in the fact that work done at Wayne State led to this international study, changing the lives of people with MS around the world.” 

Wayne State’s MS clinic treats more than 4,000 patients annually and is the largest center in the world for African-Americans.

For more information on how you can help advance MS research and treatment, visit mscenter.med.wayne.edu.